Emgrast m 500 mcg Injection
40.59$
19.04$
Emgrast M 500 mcg Injection is a synthetic form of human granulocyte colony-stimulating factor (G-CSF), designed to enhance the production of white blood cells, thereby minimizing the risk of infections in patients undergoing chemotherapy for cancer treatment. This medication plays a crucial role in boosting the immune system, making it a vital ally for those experiencing neutropenia due to their cancer therapy. However, it is important to note that individuals with certain blood disorders should avoid using Emgrast M, as it may not be suitable for everyone. While generally well-tolerated, potential side effects may include mild reactions at the injection site or flu-like symptoms. As with any medication, it is essential for patients to consult their healthcare provider before starting treatment to ensure it aligns with their medical history and overall health. Emgrast M represents a significant advancement in supportive cancer care, empowering patients to better navigate the challenges of their treatment journey. By promoting white blood cell growth, it helps patients maintain their strength during therapy and improve their overall quality of life.
الكمية
Active Pharmaceutical Ingredient
Uses
• Emgrast m 500 mcg injection is primarily utilized in patients undergoing myelosuppressive chemotherapy for non-myeloid malignancies. This medication plays a crucial role in reducing the risk of infections that can lead to febrile neutropenia. By stimulating the production of neutrophils, Emgrast m helps maintain a healthier immune response during treatment. This is especially important for patients who are more vulnerable to infections due to low white blood cell counts.
• In the context of cancer treatment, Emgrast m 500 mcg injection aids in the management of neutropenia caused by chemotherapy. Neutropenia can significantly increase the likelihood of infections, complicating the treatment process. By administering Emgrast m, healthcare providers can help patients better tolerate their chemotherapy regimens. This supportive care measure is essential for improving overall treatment outcomes.
• Emgrast m 500 mcg injection is also beneficial for patients who are at high risk of developing severe infections during chemotherapy cycles. The injection enhances the recovery of white blood cells, specifically neutrophils, which are vital for fighting off infections. By using Emgrast m, clinicians can provide a proactive approach to infection prevention in these patients. This can lead to a more effective and uninterrupted cancer treatment experience.
• For patients with cancer receiving treatment that is known to cause significant neutropenia, Emgrast m 500 mcg injection serves as a preventive measure. This medication is administered to minimize the incidence of febrile neutropenia, thus ensuring that patients remain protected during critical phases of their treatment. The timely use of Emgrast m can facilitate a smoother chemotherapy process by reducing complications related to infections. This targeted intervention is an important aspect of supportive cancer care.
Benefits
Emgrast m 500 mcg Injection is designed to stimulate the production of white blood cells, which are an important part of the body's immune system. By attacking and eliminating harmful bacteria and viruses, white blood cells help protect the body from infection and disease. By increasing the amount of white blood cells in the body.
Filgrastim Injection may help reduce the risk of infection in people with neutropenia. Neutropenia is a condition characterized by a low number of neutrophils, a type of white blood cell.
Emgrast m 500 mcg Injection helps reduce the duration of neutropenia and neutropenia-related hospitalizations in people receiving chemotherapy for cancer. It may also be used to reduce the incidence of febrile neutropenia, which is a potentially serious complication of chemotherapy that is associated with fever and a low white blood cell count.
Overall, the main benefit of Filgrastim 500 mcg Injection is its ability to help boost the body's immune system and protect it from infection.
Side Effects
Like all medicines, Filgrastim Injection may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Oropharyngeal pain
• Hair loss
• Fatigue
• Diarrhea
• Constipation
• Decreased appetite
• Cough
• Breathing problems
• Injection site reactions (pain, swelling, redness)
Common Side Effects
• Bone pain
• Weakness
• Headache
• Rash
• Nausea
• Increased lactate dehydrogenase level in blood
• Vomiting
• Increased uric acid level in the blood
How To Use
Emgrast m 500 mcg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Emgrast M 500 mcg Injection will depend on the clinical condition of the patient's age and medical history and other factors. Kindly do not self-administer now.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Emgrast M 500 mcg Injection. May increase the risk of liver damage. It is best to avoid or limit alcohol consumption while taking medication.
• Kidney: The use of Filgrastim 500 mcg Injection is safe in patients with kidney disease. No dose adjustment of Emgrast M 500 mcg is recommended. If you notice any side effects, contact your doctor.
• Breastfeeding: It is not known whether Emgrast M 500 mcg is excreted in breast milk. If you are breastfeeding and using Emgrast m 500 mcg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing breastfeeding. Your doctor can help you make the best decision for you, your health and the health of your baby.
• Liver: Filgrastim Injection is safe to use in patients with liver disease. No dose adjustment of Emgrast M 500 mcg Injection is recommended. If you notice any side effects, contact your doctor.
• Pregnancy: The use of Emgrast m 500 mcg Injection during pregnancy may not be safe, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the possible risks and benefits of using Filgrastim 500 mcg Injection during pregnancy. Your doctor can help you make the best decision for you, your health and the health of your baby.
• Driving: Emgrast m 500 mcg Injection is unlikely to affect your ability to drive or use machines. If you experience side effects such as dizziness or drowsiness while taking Filgrastim Injection, it is important not to drive a car or operate heavy machinery until the side effects have subsided.